Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Gross Profit | 32,450 | 28,450 | 16,360 | 50,010 | 24,960 |
| Operating Expenses | 42,830 | 58,690 | 79,920 | 77,830 | 52,720 |
| Operating Income | -42,830 | -58,690 | -79,920 | -77,830 | -52,720 |
| Pre-tax Income | -42,830 | -58,690 | -79,920 | -77,830 | -52,720 |
| Net Income Continuous | -42,830 | -58,690 | -79,920 | -77,830 | -52,720 |
| Net Income | $-42,830 | $-58,690 | $-79,920 | $-77,830 | $-52,720 |
| EBITDA(a) | $-33,410 | $-46,650 | $-58,380 | $43,220 | $-43,880 |